SUPN - Supernus Pharmaceuticals Inc (Healthcare: Drug Manufacturers - Specialty & Generic) Projected Earnings Date: 2025-11-03    (Delayed quote data   2025-09-12)
Last
 45.46		 Change
 ⇓ -1.20   (-2.57%)		 Volume
  415,054
Open
 46.47		 High
 46.67		 Low
 45.39
8EMA (Daily)
 45.73		 40EMA (Daily)
 41.64		 50EMA (Daily)
 40.61		 STO (Daily)
 80.682		 MACD Hist (Daily)
 -0.380
8EMA (Weekly)
 42.249		 40EMA (Weekly)
 36.02		 50EMA (Weekly)
 35.43		 STO (Weekly)
 95.915		 MACD Hist (Weekly)
 2.805
Company Profile
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com